New hemostatic agents in the combat setting
- 1 December 2009
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 49 (s5), 248S-255S
- https://doi.org/10.1111/j.1537-2995.2008.01988.x
Abstract
BACKGROUND: Hemorrhage is a leading cause of potentially preventable death in both civilian and military trauma patients. Animal data have shown that hemostatic bandages reduce hemorrhage and improve survival. This article reports recent clinical observations regarding the efficacy and evolution of use of two new hemostatic bandages employed in the global war on terrorism. METHODS: We performed a retrospective cohort review of soldiers treated with either the QuikClot or HemCon hemostatic bandages between April and October 2006. Hemostatic dressings were placed on wounds either in the field or at the combat support hospital (CSH). RESULTS: During the 6‐month study period, 1691 trauma patients were admitted to the CSH. Fifty uses of hemostatic dressings in 44 patients (2.6% of admissions) were identified. Forty patients were treated with HemCon dressings, three patients with QuikClot, and one with both QuikClot and HemCon. Eighteen percent of the dressings were used in the field, predominantly on extremity wounds (7/8). In contrast, most dressings used in the CSH were for truncal wounds (26/36 patients). Hemostatic dressings were applied to extremity wounds in prehospital and hospital settings, either alone or in conjunction with tourniquets. In surviving patients (95%), the treating surgeon determined that the hemorrhage was either stopped or greatly decreased by use of hemostatic dressings. Two of the four patients treated with QuikClot had burns from exothermic reactions, while no adverse reactions were noted with HemCon. CONCLUSIONS: Hemostatic agents stop or decrease bleeding. Whereas HemCon appears to be safe, QuikClot may produce superficial burns. These new hemostatic agents have a place in the surgical armamentarium to assist in controlling internal hemorrhage from truncal and pelvic hemorrhage, especially during damage‐control surgery.Keywords
This publication has 40 references indexed in Scilit:
- Prehospital Tourniquet Use in Operation Iraqi Freedom: Effect on Hemorrhage Control and OutcomesThe Journal of Trauma and Acute Care Surgery, 2008
- Practical Use of Emergency Tourniquets to Stop Bleeding in Major Limb TraumaJournal Of Trauma-Injury Infection and Critical Care, 2008
- Comparative Efficacy of Granular and Bagged Formulations of the Hemostatic Agent QuikClotJournal Of Trauma-Injury Infection and Critical Care, 2007
- Causes of Death in U.S. Special Operations Forces in the Global War on TerrorismAnnals of Surgery, 2007
- Testing of Modified Zeolite Hemostatic Dressings in a Large Animal Model of Lethal Groin InjuryThe Journal of Trauma and Acute Care Surgery, 2006
- Use of chitosan bandage to prevent fatal infections developing from highly contaminated wounds in miceBiomaterials, 2006
- NO-Releasing Zeolites and Their Antithrombotic PropertiesJournal of the American Chemical Society, 2005
- Advanced Hemostatic Dressing Development Program: Animal Model Selection Criteria and Results of a Study of Nine Hemostatic Dressings in a Model of Severe Large Venous Hemorrhage and Hepatic Injury in SwineThe Journal of Trauma and Acute Care Surgery, 2003
- Chitosan: potential use as a bioactive coating for orthopaedic and craniofacial/dental implantsJournal of Biomaterials Science, Polymer Edition, 2003
- Analysis of Wounds Incurred by U.S. Army Seventh Corps Personnel Treated in Corps Hospitals during Operation Desert Storm, February 20 to March 10, 1991The Journal of Trauma and Acute Care Surgery, 1996